Apple Ordered to pay Masimo $634 Million in Patent Dispute Over Blood Oxygen Technology
Table of Contents
Introduction:
A federal court jury in California has ruled that Apple infringed on patents held by Masimo, a medical technology company, related to technology used for measuring blood oxygen levels. Apple has been ordered to pay $634 million in damages and faces ongoing scrutiny regarding its Apple Watch technology.This decision stems from a long-running legal battle alleging Apple misappropriated Masimo’s technology and recruited its employees.While Apple intends to appeal, the ruling has significant implications for the wearable technology market and intellectual property rights.
Background: the Patent Dispute
The core of the dispute centers around Masimo’s pulse oximetry technology, which accurately measures blood oxygen saturation. Masimo alleges that Apple recruited key personnel and subsequently used Masimo’s patented technology in the Apple watch,specifically in features designed to monitor blood oxygen levels. https://www.masimo.com/news/masimo-apple-litigation
Apple maintains that the patent in question had expired in 2022 and covered older technology.However, the jury sided with Masimo, finding that Apple knowingly infringed on valid patent rights.
Key Events and Rulings
* Initial ITC Ban (2023): In January 2023, the U.S. International Trade Commission (ITC) initially banned the import and sale of certain Apple Watch models (Series 9 and Ultra 2) due to the patent infringement. https://www.reuters.com/technology/us-trade-commission-bans-apple-watch-imports-over-oxygen-sensor-2023-01-13/
* Temporary Workaround: Apple temporarily circumvented the ban by removing the blood oxygen measurement feature from the watches sold in the US, allowing them to resume sales.
* Modified Technology & New ITC Proceeding: Apple later reintroduced a modified version of the blood oxygen technology. The ITC is now reviewing whether this modified technology also infringes on Masimo’s patents, possibly leading to another sales ban. https://www.reuters.com/technology/us-itc-opens-new-probe-into-apple-watch-blood-oxygen-tech-2024-02-09/
* Jury Verdict (November 2024): The recent jury verdict in california awarded Masimo $634 million in damages for Apple’s infringement. https://www.cnbc.com/2024/11/14/apple-ordered-to-pay-masimo-634-million-in-blood-oxygen-patent-case.html
* Apple’s Response: Apple has stated its disagreement with the verdict and plans to appeal the decision.
Implications and Future Outlook
This case highlights the importance of intellectual property protection in the technology sector.The significant damages awarded to Masimo underscore the potential financial consequences of patent infringement.
The ongoing ITC investigation into Apple’s modified blood oxygen technology creates further uncertainty. A continued ban on Apple Watch sales could significantly impact Apple’s wearable device market share.
Beyond the immediate financial and market implications, the case raises questions about the ethics of recruiting employees from competitor companies with the intent of acquiring their intellectual property.
Primary Topic:
Patent Infringement & Legal Dispute
Primary Keyword:
Apple Masimo Patent
Secondary Keywords:
* Blood Oxygen Sensor
* Apple Watch
* Patent Dispute
* ITC Ban
* Intellectual Property
* Masimo
* Wearable Technology
* Pulse Oximetry
* Patent Infringement Damages
* Apple Legal Issues